136 related articles for article (PubMed ID: 15961781)
1. Potential risk of a common hereditary thrombophilia and adjuvant chemotherapy for low-stage breast cancer.
Ely SF
J Clin Oncol; 2005 Jun; 23(18):4242-3. PubMed ID: 15961781
[No Abstract] [Full Text] [Related]
2. Patterns of toxicity in older patients with breast cancer receiving adjuvant chemotherapy.
Hurria A; Brogan K; Panageas KS; Pearce C; Norton L; Jakubowski A; Zauderer M; Howard J; Hudis C
Breast Cancer Res Treat; 2005 Jul; 92(2):151-6. PubMed ID: 15986124
[TBL] [Abstract][Full Text] [Related]
3. Oral uracil and tegafur compared with classic cyclophosphamide, methotrexate, fluorouracil as postoperative chemotherapy in patients with node-negative, high-risk breast cancer: National Surgical Adjuvant Study for Breast Cancer 01 Trial.
Watanabe T; Sano M; Takashima S; Kitaya T; Tokuda Y; Yoshimoto M; Kohno N; Nakagami K; Iwata H; Shimozuma K; Sonoo H; Tsuda H; Sakamoto G; Ohashi Y
J Clin Oncol; 2009 Mar; 27(9):1368-74. PubMed ID: 19204202
[TBL] [Abstract][Full Text] [Related]
4. Anemia is a significant prognostic factor in local relapse-free survival of premenopausal primary breast cancer patients receiving adjuvant cyclophosphamide/methotrexate/5-fluorouracil chemotherapy.
Dubsky P; Sevelda P; Jakesz R; Hausmaninger H; Samonigg H; Seifert M; Denison U; Mlineritsch B; Steger G; Kwasny W; Stöger H; Bartsch R; Stierer M; Taucher S; Fridrik M; Schippinger W; Greil R; Pötter R; Gnant M;
Clin Cancer Res; 2008 Apr; 14(7):2082-7. PubMed ID: 18381948
[TBL] [Abstract][Full Text] [Related]
5. [Prognostication of hematotoxicity for radio- and chemotherapy in patients with breast cancer].
Ivanov SD; Iamshanov VA; Korytova LI; Khazova TV; Arzumanov AS
Vopr Onkol; 2003; 49(5):601-7. PubMed ID: 14682132
[TBL] [Abstract][Full Text] [Related]
6. Adjuvant cyclophosphamide, methotrexate, and fluorouracil in premonopausal patients with node-positive breast cancer: indirect comparison of dose and schedule in DBCG trials 77, 82, and 89.
Ejlertsen B; Mouridsen HT; Jensen MB
Acta Oncol; 2008; 47(4):662-71. PubMed ID: 18465334
[TBL] [Abstract][Full Text] [Related]
7. [Results of a study on fatigue in breast cancer patients receiving adjuvant chemotherapy: the first four days after treatment are the worst].
de Jong N; Kester AD; Schouten HC; Abu-Saad HH; Courtens AM
Pflege Z; 2007 Nov; 60(11):620-5. PubMed ID: 18062627
[TBL] [Abstract][Full Text] [Related]
8. In regards to Arcangeli et al. (Int J Radiat Oncol Biol Phys 2006;64:161-167).
Munshi A; Jalali R; Budrukar A
Int J Radiat Oncol Biol Phys; 2006 Jun; 65(2):632; author reply 632-3. PubMed ID: 16690446
[No Abstract] [Full Text] [Related]
9. [Side effects of combined antineoplastic chemotherapy on hemostasis in patients with breast cancer].
Pinto Pedrazzi AH; de Souza AM
Rev Fac Farm Odontol Ribeiro Preto; 1982; 19(1):29-41. PubMed ID: 6964932
[No Abstract] [Full Text] [Related]
10. Chemotherapy-induced nausea, vomiting, and fatigue--the role of individual differences related to sensory perception and autonomic reactivity.
Zachariae R; Paulsen K; Mehlsen M; Jensen AB; Johansson A; von der Maase H
Psychother Psychosom; 2007; 76(6):376-84. PubMed ID: 17917474
[TBL] [Abstract][Full Text] [Related]
11. Electrophysiological correlates of information processing in breast-cancer patients treated with adjuvant chemotherapy.
Kreukels BP; Schagen SB; Ridderinkhof KR; Boogerd W; Hamburger HL; van Dam FS
Breast Cancer Res Treat; 2005 Nov; 94(1):53-61. PubMed ID: 16175317
[TBL] [Abstract][Full Text] [Related]
12. Identifying good prognosis group of breast cancer patients with 1-3 positive axillary nodes for adjuvant cyclophosphamide, methotrexate and 5-fluorouracil (CMF) chemotherapy.
Lin YC; Chen SC; Chang HK; Hsueh S; Tsai CS; Lo YF; Hwang TL; Chen MF
Jpn J Clin Oncol; 2005 Sep; 35(9):514-9. PubMed ID: 16199422
[TBL] [Abstract][Full Text] [Related]
13. Dehydropyrimidine dehydrogenase deficiency in a cancer patient undergoing 5-fluorouracil chemotherapy.
Schneider HB; Becker H
Anticancer Res; 2004; 24(2C):1091-2. PubMed ID: 15154628
[TBL] [Abstract][Full Text] [Related]
14. [Secondary effects of adjuvant therapy].
Giai M; De Fabiani E; Lamberto A; Cortese P; Giardina G
Minerva Ginecol; 1985 Jun; 37(6):319-28. PubMed ID: 3162112
[No Abstract] [Full Text] [Related]
15. Effect of adjuvant systemic treatment on cosmetic outcome and late normal-tissue reactions after breast conservation.
Johansen J; Overgaard J; Overgaard M
Acta Oncol; 2007; 46(4):525-33. PubMed ID: 17497320
[TBL] [Abstract][Full Text] [Related]
16. The optimal dose of CAF regimen in adjuvant chemotherapy for breast cancer patients at stage IIB.
Khaloozadeh H; Yazdanbakhsh P; Homaei-shandiz F
Math Biosci; 2008 Jun; 213(2):151-8. PubMed ID: 18533195
[TBL] [Abstract][Full Text] [Related]
17. The potential risk of neoadjuvant chemotherapy in breast cancer patients--results from a prospective randomized trial of the Austrian Breast and Colorectal Cancer Study Group (ABCSG-07).
Taucher S; Steger GG; Jakesz R; Tausch C; Wette V; Schippinger W; Kwasny W; Reiner G; Greil R; Dubsky P; Poestlberger S; Tschmelitsch J; Samonigg H; Gnant M;
Breast Cancer Res Treat; 2008 Nov; 112(2):309-16. PubMed ID: 18080748
[TBL] [Abstract][Full Text] [Related]
18. Eosinophilic pustular folliculitis induced by chemotherapy.
Laing ME; Laing TA; Mulligan NJ; Keane FM
J Am Acad Dermatol; 2006 Apr; 54(4):729-30. PubMed ID: 16546603
[No Abstract] [Full Text] [Related]
19. Dose density in breast cancer: a simple message?
Lin NU; Gelman R; Winer EP
J Natl Cancer Inst; 2005 Dec; 97(23):1712-4. PubMed ID: 16333021
[No Abstract] [Full Text] [Related]
20. Chemotherapy induced refractory anaemia with ring sideroblasts in carcinoma breast.
Dhot PS; Sharma MC; Kumar L; Saxena R
J Assoc Physicians India; 1994 Feb; 42(2):153-4. PubMed ID: 7860480
[No Abstract] [Full Text] [Related]
[Next] [New Search]